Promising development in the fight with cancer using artificial intelligence
New privacy-preserving approach uses hospital based medical notes to refine predictions and prognosis in cancer...
New G protein inhibitor identified, with potential for cancer therapies
RI-MUHC team publishes study in Nature Communications describing a novel molecule that inhibits growth of cancer cells
RI-MUHC success in grant competition for transplantation research
Researchers awarded funds from the Canadian Donation and Transplantation Research Program for...
RI-MUHC team identifies potential diagnostic biomarker for pancreatic cancer
Study demonstrates that regenerative protein 3A/3B promotes a newly recognized precursor of pancreatic...
RI-MUHC trainee wins award at Canadian Society of Nephrology meeting
Congratulations to Tho-Alfakar Al-Aubodah!
Does the COVID-19 vaccine work for people living with HIV?
RI-MUHC scientist Dr. Cecilia Costiniuk is co-principal investigator in a new national study that hopes to answer critical questions around the...
How does the hunger-suppressing hormone leptin cross the blood-brain barrier?
Specialized cells called pericytes play a key role, reveals new work from researchers at the RI-MUHC
Recurrent miscarriage: what if the cause is genetic?
Next-generation gene sequencing may provide answers for some women dealing with recurrent pregnancy loss and prevent further miscarriages
New study paves the way to novel treatment for Triple Negative Breast Cancer
A team of researchers at the RI-MUHC found two cellular pathways involved in TNBC tumour development...
RI-MUHC study explores how to overcome the resistance of bladder tumours to radiation therapy
Work published in Nature Communications demonstrates a...